Yang Lin

Optimized dual therapy for treatment‐naive patients of Helicobacter pylori infection: A large‐scale prospective, multicenter, open‐label, randomized controlled study

P. An, Fen Wang, Ying Han, 2022, Helicobacter.

Detection of an anti-angina therapeutic module in the effective population treated by a multi-target drug Danhong injection: a randomized trial

Jun Liu, Zhong Wang, Yongyan Wang, 2021, Signal Transduction and Targeted Therapy.

Comparison of vonoprazan-based with rabeprazole-based dual therapy for treatment-naive patients of Helicobacter pylori infection: a prospective, multi-center, randomized controlled study

Pei-Yuan Li, Yun-lian Hu, Yang Lin, 2023, Journal of Gastroenterology.